GOODLIFE BRANDING LLC – Trademark Portfolio
Entity Type: 16
GOODLIFE BRANDING LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 21 (Housewares) across 5 Nice Classification classes. Currently, 7 trademarks are registered and 2 are pending. Notable registered marks include JUNENO, OPTIWAV, BLOOMODY, ROCKSTEN, and BIONERLAB. The owner is based in Dover, DE.
8 The Green, Suite #6094
Dover, DE 19901
Showing of trademarks Trademarks
Trademark Classifications
GOODLIFE BRANDING LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does GOODLIFE BRANDING LLC have?
GOODLIFE BRANDING LLC has 13 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 pending, 4 abandoned.
What trademark classes does GOODLIFE BRANDING LLC file in?
GOODLIFE BRANDING LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 21 (Housewares), Class 35 (Advertising & Business), Class 25 (Clothing), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GOODLIFE BRANDING LLC's most well-known trademarks?
GOODLIFE BRANDING LLC's registered trademark portfolio includes well-known marks such as JUNENO, OPTIWAV, BLOOMODY, ROCKSTEN, and BIONERLAB. These are among 7 currently registered trademarks in the portfolio.
What is GOODLIFE BRANDING LLC's trademark registration success rate?
GOODLIFE BRANDING LLC has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 2 applications are pending review.